Chantix
Product Images NDC 50090-4482

7 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Chantix (NDC 50090-4482). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Chantix 01)

Chemical Structure (Chantix 01)
Chemical structure depicting the molecular formula of the active ingredient in CHANTIX, showing atoms and bonds arranged in a complex molecular configuration with distinct ring structures.*
FDA Label Image

Figure 1 (Chantix 02)

Figure 1 (Chantix 02)
A bar chart comparing the efficacy percentages of CHANTIX at 0.5 mg and 1.0 mg BID versus placebo, as well as Bupropion SR 150 mg BID versus placebo across five studies. Each study shows multiple bars representing different treatments and corresponding placebo controls, with error bars indicating variability in the data.*
FDA Label Image

Figure 2 (Chantix 03)

Figure 2 (Chantix 03)
Bar chart comparing percentage outcomes across five separate studies for CHANTIX 0.5 mg BID, CHANTIX 1.0 mg BID, CHANTIX Flexible, Bupropion SR 150 mg BID, and placebo groups. Each study groups relevant treatment bars side-by-side with error bars indicating variability percentages along the y-axis ranging from 0% to 35%.*
FDA Label Image

Figure 3 (Chantix 04)

Figure 3 (Chantix 04)
A line graph comparing the percentage of continuous abstinent patients over time between CHANTIX 1.0 mg BID and placebo groups. The x-axis represents nontreatment follow-up in weeks, and the y-axis shows the percentage of continuous abstinence. Data points show a decreasing trend in abstinence percentage over time for both groups, with the CHANTIX group maintaining higher abstinence rates throughout.*
FDA Label Image

Logo (Chantix 05)

FDA Label Image

Logo (Chantix 06)

FDA Label Image

Label Image (Lbl500904482)

Label Image (Lbl500904482)
CHANTIX varenicline tablets label from A-S Medication Solutions showing each tablet contains 1.71 mg varenicline tartrate equivalent to 1 mg varenicline free base. The label includes storage instructions to store at 27 degrees Fahrenheit, and indicates the package contains 4 cartons of 56 tablets, covering 4 continuing weeks. Manufacturer Pfizer is listed with NDC 50090-4482-0.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.